Using Embedded Program Science to Improve Equity, Optimize Service Coverage, and Achieve Population-level Impact within HIV and STI Prevention and Care Programs
08:00 – 15:15 CST
Using Embedded Program Science to Improve Equity, Optimize Service Coverage, and Achieve Population-level Impact within HIV and STI Prevention and Care Programs
Location: Erie
Pre-Conference
08:30 – 15:00 CST
IUSTI World 100 Hundred Years Celebration Advanced Course
08:30 – 15:00 CST
IUSTI World 100 Hundred Years Celebration Advanced Course
O1.3 - Increasing rates of non-albicans Candida species and fluconazole resistant Candida albicans in women with recurrent vulvovaginal candidiasis in a UK region
O2.1 - Calculating the value of behavioural science and community engagement in promoting vaccination of MSM: a transmission-dynamic health-economic analysis of 4CMenB (Bexsero) vs gonorrhoea as an example
Co-Author: Dariya Nikitin, MSc, MRes – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London
Policy & Community Engagement
10:15 – 10:30 CST
O2.2 - Relationships and risk: A mixed-methods study of perceptions and management of STI/HIV risk among heterosexual-identifying men who have sex with both men and women
O2.3 - “It’s not safe for me and what would it achieve?” Acceptability of patient referral partner notification for sexually transmitted infections to adolescents and young people in Zimbabwe
O2.4 - Preparedness of pregnant women to wait for same-day results of sexually transmitted infections
Location: Chicago 9
Primary Presenter: Ranjana M S Gigi, MMed, PhD student – 1) Institute of Social and Preventive Medicine, University of Bern, Switzerland
2) Research Unit, Foundation for Professional Development, South Africa
Implementation Science
11:00 – 11:15 CST
O2.5 - Mixed methods analysis of network structures, support exchanged, and communication patterns within the social networks of transgender women in Lima, Peru
Location: Chicago 10
Primary Presenter: Cherie S Blair, MD, PhD – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA
Co-Author: Tijana Temelkovska, n/a – David Geffen School of Medicine at UCLA, Los Angeles, CA
Behavioral & Social Science
11:15 – 11:30 CST
O2.6 - Community-based integrated HIV and sexual and reproductive health services: why did we miss young men and what is it going to take to reach them?
O3.2 - Rates of reported primary and secondary syphilis among men who have sex with men compared to men who have sex with women only and women who have sex with men in 37 US states, 2018
O3.5 - Temporal Trends in HIV Status by Race/Ethnicity Among Reported Primary and Secondary Syphilis Cases Among Gay, Bisexual, and Other Men who have sex with Men — United States, 2011–2020
O3.6 - Rapid Plasma Reagin (RPR) sero-reversion after treatment and its association with Prior Treponema Pallidum infection: analysis from the PICASSO cohort among people with early syphilis in Peru
Invited Speaker: Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
SY1.2 - Decriminalization of same-sex relations and social attitudes
Location: Chicago 6
Invited Speaker: Weiming Tang – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Invited Talk
10:45 – 11:05 CST
SY1.3 - The Longest Mile: Stigma’s impact on sexual health for women in the Southern US
Location: Chicago 6
Invited Speaker: Latesha Elopre, MD, MSPH – University of Alabama at Birmingham, School of Medicine, Division of Infectious Diseases
Invited Talk
10:00 – 11:30 CST
Symposium 2 - Worldwide strategies against antimicrobial resistance
O4.1 - Exploring current etiologies of urethritis: associations of urethral microorganisms and urethritis among men attending 6 STD clinics in the US, 2017-2018
Location: Chicago 8
Primary Presenter: Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention
Epidemiology & Monitoring
14:45 – 15:00 CST
O4.2 - gyrA mutations in Mycoplasma genitalium contribute to moxifloxacin failure – a new target for resistance-guided therapy
O4.3 - MgSeq: Enabling M. genitalium identification and antimicrobial resistance detection in genital and extra-genital samples from female sex workers in Ecuador using multiplex PCR and nanopore sequencing
O5.3 - Concordance between self-reported PrEP use using a diary app and intracellular tenofovir diphosphate in the Amsterdam PrEP demonstration project
Location: Chicago 9
Primary Presenter: Eline S. Wijstma (she/her/hers) – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
Primary Presenter: Maarten Schim van der Loeff – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.
Epidemiology & Monitoring
15:15 – 15:30 CST
O5.4 - Age patterns of HSV-2 incidence and prevalence in two communities in Rakai, Uganda: a catalytic incidence model applied to population-based seroprevalence data
O5.5 - Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program
O6.1 - High uptake of Doxycycline for STI prevention (doxy-PEP) among individuals using HIV PrEP at a municipal sexual health clinic in San Francisco, California
O6.2 - Syphilis testing, incidence, and reinfection among gay and bisexual men with and without HIV in Australia over a decade spanning HIV PrEP implementation
O6.3 - Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women
O6.5 - Discontinuation of Pre-Exposure Prophylaxis and associated factors among Female Commercial Sex Workers attending the most at-risk population clinic, Mulago Hospital, Uganda
LB1.2 - Genetic diversity of Chlamydia trachomatis infection among patients presenting with genital lesions in Malawi
Location: Michigan A+B
Primary Presenter: Christopher M. Hennelly, n/a – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Epidemiology & Monitoring
15:00 – 15:15 CST
LB1.3 - Evaluating immunological responses of mRNA-based Chlamydia vaccines
Location: Michigan A+B
Primary Presenter: Wei He, n/a – Lawrence Livermore National Laboratory
Basic & Translational Science
15:15 – 15:30 CST
LB1.4 - Mpox resurgence in 2023 in Toronto, Canada – surveillance and vaccine approaches
O7.4 - Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the impact on zoliflodacin resistance
Location: Chicago 8
Primary Presenter: Daniel H. Rubin – Harvard School of Public Health
Basic & Translational Science
11:00 – 11:15 CST
O7.5 - Perceived benefits and implementation considerations for a novel lateral flow assay for the point-of-care detection of Neisseria gonorrhoeae in public healthcare facilities in South Africa
O9.1 - The clinical and genomic diversity of Treponema pallidum among early syphilis patients enrolled in a global consortium for syphilis vaccine development
Location: Chicago 10
Primary Presenter: Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Epidemiology & Monitoring
10:15 – 10:30 CST
O9.2 - Treponema pallidum Proteomic Analysis to Inform Syphilis Vaccine Development
O9.5 - Persons with Early Syphilis Make Antibodies that Differentially Recognize Extracellular Loops of Treponema pallidum Outer Membrane Proteins
Location: Chicago 10
Primary Presenter: M. Anthony Moody, MD – Duke Human Vaccine Institute, Duke Univerity, Durham, North Carolina, USA
Basic & Translational Science
11:15 – 11:30 CST
O9.6 - Comparison of Treponema pallidum genomic sequences in clinical samples and rabbit passaged isolates from early syphilis patients in Guangzhou, China
Location: Chicago 10
Primary Presenter: Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
10:00 – 11:30 CST
Spotlight 3 - Epidemic Preparedness: Mpox and Beyond
YI5 - Effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening on post-delivery prevalence and vertical transmission in Gaborone, Botswana
Location: Sheraton Ballroom
Primary Presenter: Aamirah Mussa, MPH – University of Edinburgh / Botswana Harvard Partnership
Epidemiology & Monitoring
13:43 – 13:47 CST
YI6 - Effect of antibiotic treatment on commensal Neisseria species load and presence in the oropharynx.
LB2.1 - Evolving antimicrobial resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis
Location: Michigan A+B
Primary Presenter: Teck-Phui Chua – University of Melbourne
Epidemiology & Monitoring
14:45 – 15:00 CST
LB2.2 - Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in MSM taking HIV-PrEP? Results from a randomized, multicenter, controlled trial
Location: Michigan A+B
Primary Presenter: Thibaut Vanbaelen, MD – Institute Of Tropical Medicine, Antwerp, Belgium
Clinical Science
15:00 – 15:15 CST
LB2.3 - High prevalence of STIs among men engaged in transactional sex and alcohol use in western Kenya: Important implications for STI intervention
O10 - STIs: a global health crisis, but not a lost cause
Moderator: Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
STIs: a global health crisis, but not a lost cause
Location: Chicago 8
Moderator: Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
O10.2 - STI epidemiology in the time of COVID-19 pandemic in European Union/European Economic Area (EU/EEA) countries– data artifact or real impact of the pandemic?
Location: Chicago 8
Primary Presenter: Otilia Mårdh, MD, MSc – European Centre for Diseases Prevention and Control (ECDC)
Epidemiology & Monitoring
15:00 – 15:15 CST
O10.3 - Gini coefficients for measuring the disparity in the distribution of HIV and sexually transmitted infections in both heterosexual and homosexual populations in Australia
O10.4 - Using a candidacy framework to investigate barriers and facilitators of a tailored HIV prevention and community based sexual and reproductive health intervention rural South Africa
O10.5 - Sexual and reproductive health among migrant peoples in transit through Darién, Panama: results from a rapid epidemiological study
Location: Chicago 8
Primary Presenter: Jennifer Toller Erausquin, PhD, MPH (she/her/hers) – University of North Carolina at Greensboro & Center of Population Sciences for Health Equity, College of Nursing, Florida State University
Epidemiology & Monitoring
15:45 – 16:00 CST
O10.6 - Health Systems Response for Sexual and Reproductive Health Services During COVID-19: A Systematic Review and Global Crowdsourcing Open Call
O11.2 - Global Surveillance for Antimicrobial Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2015-2022
O11.3 - Should we use the 4CMenB (Bexsero®) meningitis vaccine to protect men who have sex with men (MSM) in England against gonorrhoea? A model-based analysis of impact and cost-effectiveness.
Location: Chicago 9
Primary Presenter: Dariya Nikitin, MSc, MRes – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London
Epidemiology & Monitoring
15:15 – 15:30 CST
O11.4 - Characterisation of meningococcal vaccine-induced antibodies to Neisseria gonorrhoeae
O11.5 - Targeted metagenomic analysis shows distinct Neisseria gonorrhoeae strains at separate anatomical sites occur more commonly than mixed strain infections: implications for surveillance
Moderator: Beth Meyerson, PhD, MDiv. (she/her/hers) – Family and Community Medicine
Harm Reduction Research Lab
College of Medicine-Tucson
University of Arizona
14:30 – 16:00 CST
Reducing stigma and improving care for sexual minorities and other vulnerable populations
Moderator: Beth Meyerson, PhD, MDiv. (she/her/hers) – Family and Community Medicine
Harm Reduction Research Lab
College of Medicine-Tucson
University of Arizona
14:30 – 14:45 CST
O12.1 - Inclusion that matters – Trans and gender diverse peoples’ perspectives on sexual health services in the United Kingdom
Location: Chicago 10
Primary Presenter: Tom Witney, PhD (he/him/his) – Research Department of Primary Care and Population Health, University College London
Behavioral & Social Science
14:45 – 15:00 CST
O12.2 - Measuring and Reducing Enacted Healthcare Stigma for Sexual Minorities and People Living with HIV: An Incognito Patient Approach
O12.3 - TXTXT Implementation Preparation: Identifying Contextual Barriers and Facilitators to HIV Medication Adherence Among Youth Across 12 Clinics Nationwide
SY8.2 - Should every successful intervention be scaled-up? The SHE clinic: an inclusive, locally-specific healthcare model for women who use drugs and exchange sex in Seattle, WA
SY8.3 - Policy and clinical readiness analysis: barriers and facilitators to the integration of doxycycline post-exposure prophylaxis into Kenyan HIV PrEP programs
O13.3 - Case-Control Study of Risk Factors Associated with Mpox, San Francisco, CA, July–October, 2022
Location: Michigan A/B
Primary Presenter: Julia M. Janssen, MD – San Francisco Department of Public Health
Epidemiology & Monitoring
10:45 – 11:00 CST
O13.4 - MPOX AMONG MSM IN THE NETHERLANDS PRIOR TO MAY 2022, A RETROSPECTIVE STUDY
Location: Michigan A/B
Primary Presenter: Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre
Epidemiology & Monitoring
11:00 – 11:15 CST
O13.5 - Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022
Location: Michigan A/B
Primary Presenter: Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre
Clinical Science
11:15 – 11:30 CST
O13.6 - Rectal and Pharyngeal Mpox PCR Testing of Men Who Have Sex with Men (MSM) Suggests that Rectal Testing is More Sensitive than Lesion Testing and that Most Infections Are Asymptomatic
O15.1 - Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and fertility in women: final results of the Netherlands Chlamydia Cohort Study (NECCST)
Location: Sheraton 1
Primary Presenter: Zoïe W. Alexiou, MSc (she/her/hers) – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands.
zoie.alexiou@rivm.nl
Epidemiology & Monitoring
10:15 – 10:30 CST
O15.2 - Oral inoculation of Chlamydia trachomatis (CT) can lead to viable rectal CT infection
O15.3 - Do we understand rectal chlamydia infections in women? A study including different anatomical sites, quantification and viability of Chlamydia trachomatis in two Swedish STI-clinics
Location: Sheraton 1
Primary Presenter: Mimmi Wänn – Department of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden
Clinical Science
10:45 – 11:00 CST
O15.4 - Characterising CD4+ T cell responses to Chlamydia trachomatis in highly exposed young South African women
Location: Sheraton 1
Primary Presenter: Rubina Bunjun, PhD (she/her/hers) – Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Basic & Translational Science
11:00 – 11:15 CST
O15.5 - Evaluating Chlamydia trachomatis and Neisseria Gonorrhoeae screening among asymptomatic pregnant women to prevent preterm birth and low birth weight in Gaborone, Botswana.
O15.6 - Chlamydia trachomatis IgG seropositivity: who becomes and remains positive?
Location: Sheraton 1
Primary Presenter: Zoïe W. Alexiou, MSc (she/her/hers) – National Institute For Public Health And The Environment (RIVM), Bilthoven, the Netherlands. Maastricht University, Maastricht, the Netherlands.
zoie.alexiou@rivm.nl
Epidemiology & Monitoring
10:00 – 11:30 CST
Symposium 10 - Advances in accessing, analysing and disseminating STI data
